LUXA BIOTECHNOLOGY LLC
🇺🇸United States
Safety and Tolerability of RPE Stem Cell-derived RPE(RPESC-RPE) Transplantation in Patients With Dry Age-related Macular Degeneration (AMD)
Phase 1
Recruiting
- Conditions
- Dry Age-related Macular Degeneration
- Interventions
- First Posted Date
- 2020-11-13
- Last Posted Date
- 2025-04-11
- Lead Sponsor
- Luxa Biotechnology, LLC
- Target Recruit Count
- 18
- Registration Number
- NCT04627428
- Locations
- 🇺🇸
University of Michigan Kellogg Eye Center, Ann Arbor, Michigan, United States
© Copyright 2025. All Rights Reserved by MedPath